Vigilant Capital Management, LLC Laboratory Corp Of America Holdings Transaction History

Vigilant Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 07, 2022	SELL	$259.82 - $298.18 $41,571 - $47,708	-160 Reduced 89.89%	18 $5,000
Q4 2021 Jan 06, 2022	SELL	$271.6 - $314.21 $4,074 - $4,713	-15 Reduced 7.77%	178 $56,000
Q3 2021 Oct 08, 2021	BUY	$274.82 - $308.34 $9,069 - $10,175	33 Added 20.63%	193 $54,000
Q2 2021 Jul 09, 2021	SELL	$251.87 - $278.14 $54,655 - $60,356	-217 Closed	0 $0
Q4 2020 Jan 14, 2021	SELL	$186.91 - $214.42 $25,232 - $28,946	-135 Reduced 38.35%	217 $44,000
Q3 2020 Oct 15, 2020	BUY	$167.03 - $201.3 $58,794 - $70,857	352 New	352 $66,000
Q2 2018 Jul 11, 2018	SELL	$160.33 - $189.41 $8,657 - $10,228	-54 Closed	0 $0
Q1 2018 Apr 04, 2018	BUY	$161.53 - $178.11 $8,722 - $9,617	54 New	54 $9,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Vigilant Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Vigilant Capital Management, LLC with notifications on news.